v3.25.2
Balance Sheet Details (Tables)
 6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Available-for-Sale Investments
The following is a summary of our available-for-sale investments (in thousands):
June 30, 2025
Amortized CostGross Unrealized
Gains		Gross Unrealized
Losses		Estimated Fair
Value
U.S. treasury bills$9,930 $— $(2)$9,928 
U.S. government agency obligations8,918 — (1)8,917 
U.S. corporate debt securities3,382 — — 3,382 
U.S. commercial paper6,932 — (2)6,930 
Foreign commercial paper1,980 — (1)1,979 
Total$31,142 $— $(6)$31,136 
December 31, 2024
Amortized CostGross Unrealized
Gains		Gross Unrealized
Losses		Estimated Fair
Value
U.S. treasury bills$5,934 $2 $— $5,936 
U.S. government agency obligations8,326 — (1)8,325 
U.S. corporate debt securities1,387 — — 1,387 
U.S. commercial paper1,831 — — 1,831 
Foreign commercial paper980 — — 980 
Total$18,458 $2 $(1)$18,459 
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consist of the following (in thousands):
June 30, 2025December 31, 2024
Prepaid expenses$5,567 $2,149 
Interest receivables193 262 
Other assets228 53 
Total prepaid expenses and other current assets$5,988 $2,464 
Schedule of Accrued Liabilities
Accrued liabilities consist of the following (in thousands):
June 30, 2025December 31, 2024
Accrued clinical, manufacturing and professional expense$5,574 $4,211 
Accrued compensation and benefits1,656 3,342 
Other accrued expenses703 249 
Total accrued liabilities$7,933 $7,802